Ok, where is the $2.65M received by Bintai before 10/31/2020 in there? So Bintai must have paid the funds to GNBT and GNBT is going to give the funds to NGIO as needed to fund the trials. Afterall, NGIO is a separate company now and therefore should be running the trials, not GNBT. Looking forward to seeing the GNBT 10Q to see that money there.
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.